These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27018830)
1. Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. DeAngelis H; Scarpino SV; Fitzpatrick MC; Galvani AP; Althouse BM JAMA Pediatr; 2016 May; 170(5):459-65. PubMed ID: 27018830 [TBL] [Abstract][Full Text] [Related]
2. Pertussis in adolescents and adults: should we vaccinate? Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany. Tormans G; Van Doorslaer E; van Damme P; Clara R; Schmitt HJ Eur J Pediatr; 1998 May; 157(5):395-401. PubMed ID: 9625337 [TBL] [Abstract][Full Text] [Related]
4. Which strategy for pertussis vaccination today? Girard DZ Paediatr Drugs; 2002; 4(5):299-313. PubMed ID: 11994035 [TBL] [Abstract][Full Text] [Related]
5. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. Gambhir M; Clark TA; Cauchemez S; Tartof SY; Swerdlow DL; Ferguson NM PLoS Comput Biol; 2015 Apr; 11(4):e1004138. PubMed ID: 25906150 [TBL] [Abstract][Full Text] [Related]
6. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A; Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665 [TBL] [Abstract][Full Text] [Related]
7. Pertussis in the Era of New Strains of Bordetella pertussis. Souder E; Long SS Infect Dis Clin North Am; 2015 Dec; 29(4):699-713. PubMed ID: 26337739 [TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccination and whooping cough: and now what? Guiso N Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131 [TBL] [Abstract][Full Text] [Related]
9. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group]. Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362 [TBL] [Abstract][Full Text] [Related]
10. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study. Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453 [TBL] [Abstract][Full Text] [Related]
11. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
12. Pertussis immunization of adolescents in the United States: an economic evaluation. Caro JJ; Getsios D; El-Hadi W; Payne K; O'Brien JA Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S75-82. PubMed ID: 15876932 [TBL] [Abstract][Full Text] [Related]
14. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780 [TBL] [Abstract][Full Text] [Related]
15. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
16. Asymptomatic transmission and the resurgence of Bordetella pertussis. Althouse BM; Scarpino SV BMC Med; 2015 Jun; 13():146. PubMed ID: 26103968 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of pertussis vaccination in adults. Lee GM; Murphy TV; Lett S; Cortese MM; Kretsinger K; Schauer S; Lieu TA Am J Prev Med; 2007 Mar; 32(3):186-193. PubMed ID: 17296470 [TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia. Kurova N; Timofeeva EV; Guiso N; Macina D Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334 [TBL] [Abstract][Full Text] [Related]
19. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of São Paulo, Brazil. Fernandes EG; Sartori AMC; de Soárez PC; Carvalhanas TRMP; Rodrigues M; Novaes HMD BMC Infect Dis; 2018 Mar; 18(1):126. PubMed ID: 29534683 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015. Latasa P; García-Comas L; Gil de Miguel A; Barranco MD; Rodero I; Sanz JC; Ordobás M; Arce A; Garrido-Estepa M Vaccine; 2018 Mar; 36(12):1643-1649. PubMed ID: 29439872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]